Free PSA
Screening for the prostate cancer, monitoring treatment effectiveness, assess risk & detect recurrence
Free PSA measure the amount of PSA that is not bound to proteins in the blood, helping to diagnose prostate cancer and contributing to the staging of cancer and monitoring of cancer treatment, including treatment response and recurrence in cancer patients.
- Diagnosis diseases
- Prostate Cancer, Prostatitis, Benign Prostatic Hyperplasia (BPH)
Available Instruments
About Using Reagent
-
Sample Types
Whole Blood, Serum, Plasma -
Reaction Time
12 mins -
Detection Range
0.05-50 ng/mL -
Indication
Prostate cancer, prostatitis, benign prostatic hyperplasia (BPH)
In Your Medical Field
Evaluating the ratio of free PSA to total PSA measures the likelihood of prostate cancer and improves overall specificity in the diagnosis, treatment, and evaluation of prostate cancer, including monitoring treatment effectiveness and recurrence. Generally, a lower percentage of free PSA in relation to total PSA is associated with a higher risk of prostate cancer, while a higher percentage may suggest a lower risk.